Cantor Fitzgerald Predicts Legend Biotech FY2026 Earnings
Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Cantor Fitzgerald issued their FY2026 earnings estimates for Legend Biotech in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst R. Bienkowski anticipates that the company will post earnings of $0.24 per share for the year. Cantor Fitzgerald has a “Overweight” rating and […]
Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Cantor Fitzgerald issued their FY2026 earnings estimates for Legend Biotech in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst R. Bienkowski anticipates that the company will post earnings of $0.24 per share for the year. Cantor Fitzgerald has a “Overweight” rating and […]
